Alarm Clock-Based Reminder for Improving Low Adherence on Option B Plus Antiretroviral Therapy Among HIV Positive Pregnant and Lactating Mothers in Northern Ethiopia

References

• World Health Organization. The Strategic Use of Antiretrovirals for Treatment and Prevention of HIV Infection: Report of a WHO Technical Consultation. Geneva: Switzerland; 11 14–16, 2011.
   Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS, World Health Organization WHO). AIDS Epidemic Update, 2009. UNAIDS; 2009.
   Google Scholar
• Demographic E. Health Survey 2011 Central Statistical Agency Addis Ababa. Maryland, USA: Ethiopia ICF International Calverton; 2012.
   Google Scholar
• Besada D, Van Cutsem G, Goemaere E, Ford N, Bygrave H, Lynch S. The case for option B and optional B+: ensuring that South Africa’s commitment to eliminating mother-to-child transmission of HIV becomes a reality. South Afr J HIV Med. 2012;13(4):178–181. doi:10.4102/sajhivmed.v13i4.112
   Google Scholar
• World Health Organization.Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach-2010 version. World Health Organization; 2010.
   Google Scholar
• Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. JAIDS-HAGERSTOWN MD. 2002;29(5):484–494.
   Google Scholar
• Awittor RJ Adherence to Antiretroviral Therapy (Art) Among Hiv Positive Women at Antiretroviral Centers in Tema [Doctoral dissertation]. University of Ghana;2012.
   Google Scholar
• World Health Organization. Global monitoring framework and strategy for the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (EMTCT); 2012.
   Google Scholar
• Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Curr Drug Targets. 2011;11(2):167–174.
   Google Scholar
• World Health Organization. Success Factors for Women’s and Children’s Health: Ethiopia; 2015.
   Google Scholar
• Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-, middle and high income countries: a systematic review and meta-analysis. AIDS (London, England). 2012;26(16):2039. doi:10.1097/QAD.0b013e328359590f
   PubMed Web of Science ®Google Scholar
• Federal Ministry of Health. The national strategic plan for elimination of mother to child transmission of HIV (e-MTCT of HIV) 2013–2015;2013.
   Google Scholar
• Federal H, Prevention Al. Control office, federal ministry of health: single point HIV prevalence estimate; 2007.
   Google Scholar
• Desta ML, Saravanan M, Hilekiros H, et al. HIV prevalence and risk factors in infants born to HIV positive mothers, measured by dried blood spot real-time PCR assay in Tigray, Northern Ethiopia. BMC Pediatr 2019;19(1):257. doi:10.1186/s12887-019-1636-y
   Google Scholar
• Ebuy H, Yebyo H, Alemayehu M. Level of adherence and predictors of adherence to the option B+ PMTCT programme in Tigray, northern Ethiopia. Int J Infect Dis 2015;33:123–129. doi:10.1016/j.ijid.2014.12.026
   Google Scholar
• Steel G, Nwokike J, Joshi MP. Development of a multi-method tool to measure ART adherence in resource-constrained settings: the South Africa experience. RPM Plus 2007;6
   Google Scholar
• World Health Organization. Global Guidance on Criteria and Processes for Validation: Elimination of Mother-To-Child Transmission of HIV and Syphilis. 2017.
   Google Scholar
• Ekama SO, Herbertson EC, Addeh EJ, et al. Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women. J Pregnancy. 2012;23:2012.
   Google Scholar
• Noiman A. CHANGES in adherence and program retention and associated factors among hiv-infected women receiving option b+ for preventing mother-to-child transmission of hiv in Kampala, Uganda: a mixed methods approach [Doctoral dissertation]. Johns Hopkins University; 2017
   Google Scholar
• Decker S, Rempis E, Schnack A, et al. Prevention of mother-to-child transmission of HIV: postpartum adherence to option B+ until 18 months in Western Uganda. PLoS One. 2017;12(6):e0179448. doi:10.1371/journal.pone.017944828662036
   PubMedGoogle Scholar
• Tsegaye D, Deribe L, Wodajo S. Levels of adherence and factors associated with adherence to option B+ prevention of mother-to-child transmission among pregnant and lactating mothers in selected government health facilities of South Wollo Zone, Amhara Region, northeast Ethiopia, 2016. Epidemiol Health. 2016;38:e2016043. doi:10.4178/epih.e201604327733034
   PubMedGoogle Scholar
• Haas AD, Msukwa MT, Egger M, et al. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in malawi’s option B+ program. Clin Infect Dis. 2016;63(9):1227–1235. doi:10.1093/cid/ciw50027461920
   PubMed Web of Science ®Google Scholar
• Shibabaw W, Melkam W, Shiabbaw A. Adherence to anti-retroviral therapy among hiv positive pregnant women in Ayder Refferral Hospital, Northern Ethiopia. J Antivir Antiretrovir. 2018;10(2):18–22. doi:10.4172/1948-5964.1000175
   Google Scholar
• Tadios Y, Davey G. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia. Ethiop Med J. 2006;44(3):237–244.17447389
   PubMedGoogle Scholar
• Lencha MT. Adherence to option B+ and associated factors among pregnant women on pmtct services at public health facilities of East Shawa Zone, Oromia, Ethiopia. J Womens Health Reprod Med. 2018;2(1):2.
   Google Scholar
• Belayihun B, Negus R. Antiretroviral treatment adherence rate and associated factors among people living with HIV in Dubti Hospital, Afar Regional State, East Ethiopia. Int Sch Res Notices. 2015;2015.
   PubMedGoogle Scholar
• Ayuo P, Musick B, Liu H, et al. Frequency and factors associated with adherence to and completion of combination antiretroviral therapy for prevention of mother to child transmission in western Kenya. J Int AIDS Soc. 2013;16(1):17994. doi:10.7448/IAS.16.1.1799423336727
   PubMedGoogle Scholar
• Kirsten I, Sewangi J, Kunz A, et al. Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS One. 2011;6(6):e21020. doi:10.1371/journal.pone.002102021695214
   PubMed Web of Science ®Google Scholar
• Boateng D, Kwapong GD, Agyei-Baffour P. Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional study. BMC Womens Health. 2013;13(1):2. doi:10.1186/1472-6874-13-223336813
   PubMedGoogle Scholar
• Shubber Z, Mills EJ, Nachega JB, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183. doi:10.1371/journal.pmed.100218327898679
   PubMed Web of Science ®Google Scholar
• Wasti SP, Simkhada P, Randall J, Freeman JV, Van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7(5):e35547. doi:10.1371/journal.pone.003554722563464
   PubMed Web of Science ®Google Scholar
• Pramila K, Gharti KP, Sharma S. Effect of adherence to anti-retroviral therapy on cd4 t cells and hiv viral load in Nepalese Tertiary Care Hospital; 2017.
   Google Scholar
• Kapesa A, Magesa D, William A, Kaswija J, Seni J, Makwaya C. Determinants of immunological failure among clients on the first line treatment with highly active antiretroviral drugs in Dar es Salaam, Tanzania. Asian Pac J Trop Biomed. 2014;4:S620–4. doi:10.12980/APJTB.4.2014APJTB-2013-0035
   Google Scholar
• Kim MH, Zhou A, Mazenga A, et al. Why did I stop? Barriers and facilitators to uptake and adherence to ART in Option B+ HIV care in Lilongwe, Malawi. PLoS One. 2016;11(2):e0149527. doi:10.1371/journal.pone.014952726901563
   PubMed Web of Science ®Google Scholar
• Atanga PN, Ndetan HT, Fon PN, et al. Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive cameroonian women at 6 and 12 months after initiating option B+. BMC Pregnancy Childbirth. 2018;18(1):418. doi:10.1186/s12884-018-2058-930359239
   PubMedGoogle Scholar
• Cohen CJ, Meyers JL, Davis KL. Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV. BMJ Open. 2013;3(8). doi:10.1136/bmjopen-2013-003028
   Web of Science ®Google Scholar